Jun Yan
Director/Board Member presso JIANGSU SHENTONG VALVE CO., LTD.
Profilo
Jun Yan currently works at Jiangsu Shentong Valve Co., Ltd., as Independent Director from 2019, Shanghai Allist Pharmaceuticals Co., Ltd., as Independent Director from 2019, and Shanghai Haihe Biopharma Co., Ltd., as Independent Director from 2020.
Mr. Yan also formerly worked at Wenfeng Great World Chain Development Corp., as Independent Director.
Mr. Yan received his undergraduate degree from Fudan University.
Posizioni attive di Jun Yan
Società | Posizione | Inizio |
---|---|---|
JIANGSU SHENTONG VALVE CO., LTD. | Director/Board Member | 25/07/2019 |
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. | Director/Board Member | 28/11/2019 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Director/Board Member | 08/09/2020 |
Precedenti posizioni note di Jun Yan
Società | Posizione | Fine |
---|---|---|
WENFENG GREAT WORLD CHAIN DEVELOPMENT CORPORATION | Director/Board Member | - |
Formazione di Jun Yan
Fudan University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
JIANGSU SHENTONG VALVE CO., LTD. | Producer Manufacturing |
WENFENG GREAT WORLD CHAIN DEVELOPMENT CORPORATION | Retail Trade |
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. | Health Technology |
Aziende private | 1 |
---|---|
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |
- Borsa valori
- Insiders
- Jun Yan